Moderna CEO Pay Hits $19.9M As Cost Cuts Boost Cash Bonus
17 Mar 2026 //
FIERCE PHARMA
Roivant Units Reach $2.25B Patent Settlement With Moderna
03 Mar 2026 //
GLOBENEWSWIRE
BioNTech Sues Moderna For Patent Infringement Over COVID Shot
20 Feb 2026 //
REUTERS
Dr. David Berman To Join Moderna As Chief Development Officer
30 Jan 2026 //
PHARMIWEB
Moderna To Present At Piper Sandler Healthcare Conference
18 Nov 2025 //
PHARMIWEB
Moderna Unveils Q3 2025 Financials & Business Updates
06 Nov 2025 //
PHARMIWEB
Moderna Posts 4th-Straight Earnings Drop but Bleeding Is Slowing
06 Nov 2025 //
BIOSPACE
Moderna To Release Q3 2025 Financial Results On November 6
16 Oct 2025 //
PHARMIWEB
Moderna Plans to Lay Off 10% of Workforce to Cut Costs
01 Aug 2025 //
REUTERS
Moderna CEO Stéphane Bancel Gets Pay Bump Despite Revenue Drop
12 Mar 2025 //
FIERCE PHARMA
Genevant, Arbutus File Global Patent Cases Against Moderna
03 Mar 2025 //
GLOBENEWSWIRE
Moderna picks Merck KGaA, Roivant alum as marketing chief
06 Feb 2025 //
FIERCE PHARMA
Moderna, Novo slammed for breaching UK drug marketing code again
27 Jan 2025 //
FIERCE PHARMA
Moderna Announces Updates on Pandemic Influenza Program
17 Jan 2025 //
ACCESSWIRE
Personalis Advances Strategy with Merck Investment, Moderna Deal
19 Dec 2024 //
BUSINESSWIRE
Moderna Named a Top Employer by Science for Tenth Consecutive Year
24 Oct 2024 //
ACCESSWIRE
Moderna rebuked over second successive Spikevax marketing breach
30 Sep 2024 //
FIERCE PHARMA
Moderna Cuts R&D Spending, Focuses on Oncology
13 Sep 2024 //
CONTRACTPHARMA
Moderna forecasts lower sales next year, shares near four-year low
12 Sep 2024 //
REUTERS
EU approves Moderna`s RSV vaccine for over 60s
24 Aug 2024 //
ECONOMICTIMES
Moderna cuts 2024 sales forecast, sees low EU vaccine revenue into 2026
01 Aug 2024 //
REUTERS
Moderna Reports Q2 2024 Results And Provides Business Updates
01 Aug 2024 //
ACCESSWIRE
CDC Recommendations Reduce Long-Term US RSV Market Value: Airfinity
29 Jul 2024 //
FIERCE PHARMA
Should Merck Buy Out Moderna on Keytruda–Cancer Vaccine Partnership?
24 Jul 2024 //
BIOSPACE
Moderna co-founder Robert Langer to step down from vaccine maker`s board
24 Jul 2024 //
REUTERS
Pfizer moves forward with once-daily weight-loss pill
12 Jul 2024 //
REUTERS
Moderna Receives BARDA Award For MRNA-Based Pandemic Influenza Vaccine
02 Jul 2024 //
ACCESSWIRE
Carisma Announces Nomination of First In Vivo CAR-M Development Candidate
27 Jun 2024 //
PR NEWSWIRE
GSK, Moderna, Novartis and more join Slope in new biospecimen consortium
25 Jun 2024 //
FIERCE BIOTECH
Moderna stock is lone omen of bird flu pandemic
17 Jun 2024 //
REUTERS
Dr. Tim Garnett, Former CMO of Eli Lilly, Joins Lindus Health`s Advisory Board
08 May 2024 //
PR NEWSWIRE
Moderna takes a `Coffee Break` with new social media series
01 May 2024 //
FIERCE PHARMA
Moderna goes all in on GenAI to drive 15-drug launch goal
25 Apr 2024 //
PRESS RELEASE
Viatris, eyeing a return to growth, taps Moderna, Amgen alum as Cco
16 Apr 2024 //
FIERCE PHARMA
Moderna Betrays Africa, Says AHF
11 Apr 2024 //
BUSINESSWIRE
Arbutus Announces Claim Ruling in its Ongoing Patent Infring Against Moderna
04 Apr 2024 //
GLOBENEWSWIRE
Moderna shares fall after judge sides with Arbutus in patent fight
04 Apr 2024 //
REUTERS
Moderna`s CEO takes slight pay cut during `transition year`
12 Mar 2024 //
FIERCE PHARMA
Moderna lays off manufacturing workers in Massachusetts
02 Mar 2024 //
ENDPTS
Investors hone in on Moderna’s RSV, CMV prospects
22 Feb 2024 //
FIERCE BIOTECH
Moderna-backed Metagenomi cuts US IPO valuation target to $563 mln
08 Feb 2024 //
REUTERS
Respiratory Syncytial Virus (RSV): What You Need to Know
07 Feb 2024 //
PRESS RELEASE
Moderna to Report Fourth Quarter and Full Year 2023 Financial Results
01 Feb 2024 //
ACCESSWIRE
Moderna Named to Fortune`s List of World`s Most Admired Companies
31 Jan 2024 //
ACCESSWIRE
Robert S. Langer, Co-Founder of Moderna, Joins Lindus Health`s Advisory Board
25 Jan 2024 //
PR NEWSWIRE
Moderna warns of losses and charts path back to profits: #JPM24
10 Jan 2024 //
ENDPTS
Moderna Provides Pipeline Updates at 42nd J.P. Morgan Healthcare Conference
08 Jan 2024 //
PRESS RELEASE
Moderna 2023 Shareholder Letter
02 Jan 2024 //
PRESS RELEASE
Moderna jumps on Oppenheimer upgrade, 2025 sales growth goal
02 Jan 2024 //
REUTERS
Verisante Technology, Inc. Announces 2023 AGM Results
20 Dec 2023 //
ACCESSWIRE
Moderna to Host Second ESG Investor Event on December 7th, 2023
14 Nov 2023 //
ACCESSWIRE
IR Insights: Recapping our Q3 Earnings Report
06 Nov 2023 //
MODERNATX
Moderna could be open to out-licensing if sales struggle: Bancel
02 Nov 2023 //
FIERCE BIOTECH
Enlivex lays off 50% of staff; Moderna warns against TRC Capital
11 Sep 2023 //
ENDPTS
Why US giant Moderna is moving into Stockholm
15 Jun 2023 //
THELOCAL
Amgen snags Moderna exec as CMO
15 Jun 2023 //
FIERCE BIOTECH
Moderna investing $322M to set up nearby manufacturing site
23 May 2023 //
FIERCE PHARMA
Moderna goes after Alnylam, filing counterclaims in Spikevax patent suit
15 May 2023 //
ENDPTS
Moderna CEO criticised for earning 12,000 times of a minimum wage worker
04 May 2023 //
BUSINESS-STANDARD
Big Pharma-partnered clinical trial matchmaker secures $20M to improve platform
29 Mar 2023 //
ENDPTS

Market Place
Sourcing Support